"Our office provides comprehensive care for women with gynecological cancers. Our team is committed to treating patients with dignity, respect, and genuine concern for the"

During the past decade, Schwartz Gynecologic Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Schwartz Gynecologic Oncology" are "Epithelial Ovarian Cancer" (1 trials), "Fallopian Tube Cancer" (1 trials), "Ovarian Cancer" (1 trials) and "Peritoneal Neoplasms" (1 trials). Many other conditions were trialed in "Schwartz Gynecologic Oncology" in a lesser frequency.

Most popular intervention types in "Schwartz Gynecologic Oncology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Farletuzumab, Carboplatin, and PLD" (1 trials), "carboplatin" (1 trials), "phenoxodiol" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Schwartz Gynecologic Oncology" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Schwartz Gynecologic Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Schwartz Gynecologic Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Schwartz Gynecologic Oncology, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".